Dr. Verticelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1250 S Collegeville Rd
Collegeville, PA 19426Phone+1 610-917-6502
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1998 - 2002
- Georgetown University School of MedicineClass of 1998
Certifications & Licensure
- PA State Medical License 2001 - 2024
Publications & Presentations
PubMed
- 89 citationsRandomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers.Kathleen M. Weisel, Nicola Scott, Debra J. Tompson, Bartholomew J. Votta, Sujith Madhavan
Pharmacology Research & Perspectives. 2017-12-01 - 12 citationsDeamidation of Polyanion‐stabilized Acidic Fibroblast Growth FactorDavid B. Volkin, Adeline M. Verticelli, Mark W. Bruner, Kimberly E. Marfia, P. K. Tsai
Journal of Pharmaceutical Sciences. 1995-01-01 - 2 citationsFirst-in-Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.Melisa Cooper, Robin O'Connor-Semmes, Beth Ann Reedy, Kimberley Hacquoil, Peter D. Gorycki
Clinical Pharmacology in Drug Development. 2019-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: